Glucagon

In the US, Glucagon (glucagon systemic) is a member of the drug class glucose elevating agents and is used to treat Diagnosis and Investigation and Hypoglycemia.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

H04AA01

CAS registry number (Chemical Abstracts Service)

0016941-32-5

Chemical Formula

C153-H225-N43-O49-S

Molecular Weight

3482

Therapeutic Category

Antidote: Insulin antagonist

Chemical Name

Glucagon

Foreign Names

  • Glucagonum (Latin)
  • Glucagon (German)
  • Glucagon (French)
  • Glucagon (Spanish)

Generic Names

  • Glucagon (OS: BAN, DCF, JAN)
  • Glucagone (OS: DCIT)
  • Glukagon (IS)
  • HG Faktor (IS)
  • Glucagon (PH: Ph. Eur. 7, USP 34)
  • Glucagon, Human (PH: BP 2011)
  • Glucagon, human (PH: Ph. Eur. 7)
  • Glucagone (PH: Ph. Eur. 7)
  • Glucagonum (PH: Ph. Eur. 7)
  • Glucagonum humanum (PH: Ph. Eur. 7)

Brand Names

  • Glucagen
    Novo Nordisk, Bosnia & Herzegowina; Novo Nordisk, Ireland; Novo Nordisk, India; Novo Nordisk, Lithuania; Novo Nordisk, Singapore; Novo Nordisk, Tunisia; Novo Nordisk, Taiwan
  • GlucaGen
    Novo Nordisk, Canada
  • Glucagon Diagonostic
    Lilly, United States
  • Glucagon Emergency
    Lilly, United States
  • Glucagon Lilly
    Lilly, Canada
  • Glucagon
    Eli Lilly, Brazil
  • Glucagon G Novo
    Novo Nordisk, Japan
  • Glucagen Hypokit
    Novo Nordisk, Argentina
  • GlucaGen Novo Nordisk
    Novo Nordisk, Switzerland
  • Glucagen
    Novo Nordisk, Australia; Novo Nordisk, Belgium; Novo Nordisk, Bulgaria; Novo Nordisk, Bahrain; Novo Nordisk, Chile; Novo Nordisk, Czech Republic; Novo Nordisk, Denmark; Novo Nordisk, Spain; Novo Nordisk, Finland; Novo Nordisk, France; Novo Nordisk, United Kingdom; Novo Nordisk, Georgia; Novo Nordisk, Greece; Novo Nordisk, Hong Kong; Novo Nordisk, Hungary; Novo Nordisk, Israel; Novo Nordisk, Iceland; Novo Nordisk, Italy; Novo Nordisk, Lithuania; Novo Nordisk, Malta; Novo Nordisk, Malaysia; Novo Nordisk, Netherlands; Novo Nordisk, New Zealand; Novo Nordisk, Oman; Novo Nordisk, Portugal; Novo Nordisk, Romania; Novo Nordisk, Serbia; Novo Nordisk, Russian Federation; Novo Nordisk, Slovakia; Novo Nordisk, Turkey; Novo Nordisk, United States; Novo Nordisk, South Africa
  • GlucaGen
    Novo Nordisk, Austria; Novo Nordisk, Germany; Novo Nordisk, Estonia; Novo Nordisk, Croatia (Hrvatska); Novo Nordisk, Latvia; Novo Nordisk, Poland; Novo Nordisk, Slovenia
  • Glucagon Novo Nordisk
    Novo Nordisk, Sweden
  • Glucagon
    Eli Lilly, Lithuania; Lilly, Canada; Lilly, United States; Novo Nordisk, Norway

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web1)